Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein

Neuroreport
Rudi D'HoogePeter Paul De Deyn

Abstract

Cognitive and other behavioural characteristics of 3-month-old heterozygous male transgenic mice expressing the 751-amino acid isoform of human amyloid precursor protein (hAPP751) under the control of a neurone-specific enolase promoter, were compared with those of age-matched non-transgenic control males. No difference was found between hAPP751 transgenics and non-transgenic controls in passive avoidance learning, or in motor coordination. Significantly decreased measures were found in the open field test and in cage activity indicative of general hypoactivity in hAPP751 transgenics. In water maze training, hAPP751 males required significantly longer to locate the hidden platform. This was not due to decreased swimming velocity in hAPP751 mice, but rather to increased path lengths. This suggests a purely spatial learning deficit in hAPP751 males even though their performance during a final spatial test, the probe trail that followed water maze training, was indistinguishable from that of controls. Decreased activity and impaired spatial learning were also reported in an independent study of hAPP751-expressing transgenics showing beta-amyloid immunoreactive deposits and altered tau protein. Since such histopathological alterati...Continue Reading

Citations

Sep 22, 2001·Physiology & Behavior·C Janus, D Westaway
Aug 23, 2001·Brain Research. Brain Research Reviews·R D'Hooge, P P De Deyn
May 4, 2001·Trends in Genetics : TIG·P F ChapmanM F Ramsay
Feb 13, 2001·Neurobiology of Aging·J JosephM A Smith
May 30, 2001·Neurobiology of Aging·M N GordonG W Arendash
Dec 25, 2002·Neurobiology of Aging·P H KellyB Sommer
Dec 21, 2000·Experimental Gerontology·O ToussaintJ Vanfleteren
Jun 23, 1998·Current Opinion in Neurobiology·H P Lipp, D P Wolfer
Jan 25, 2003·The European Journal of Neuroscience·Debby Van DamPeter P De Deyn
Sep 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ottavio V VitoloMichael Shelanski
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MezianeA Ungerer
Oct 11, 2011·Molecular Neurodegeneration·Charlotte DelaySébastien S Hébert
Jun 5, 1999·Reviews in the Neurosciences·C Sturchler-Pierrat, B Sommer
Jul 5, 2005·Expert Opinion on Investigational Drugs·B Sommer
Mar 1, 2012·Neuroscience and Biobehavioral Reviews·R LalondeC Strazielle
Nov 19, 2004·The European Journal of Neuroscience·Ellen VloeberghsPeter Paul De Deyn
Sep 19, 2014·Acta Neuropathologica Communications·Gary P MorrisBryce Vissel
Aug 16, 2012·The Biochemical Journal·Andrew F Teich, Ottavio Arancio
Oct 24, 2006·Neuroscience and Biobehavioral Reviews·L Giménez-LlortA Fernández-Teruel
Sep 26, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R G Morris
Apr 29, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiulian SunWeihong Song
Oct 27, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marcel W CoolenGerard J M Martens
Nov 24, 2019·Nature Communications·Guillaume EtterSylvain Williams
Apr 27, 2005·Brain Research. Brain Research Reviews·Milla Koistinaho, Jari Koistinaho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.